# Ascending Dose Study of the Safety and Tolerability of REGN728 in Healthy Volunteers

> **NCT01197391** · PHASE1 · COMPLETED · sponsor: **Regeneron Pharmaceuticals** · enrollment: 48 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** REGN728

## Key facts

- **NCT ID:** NCT01197391
- **Lead sponsor:** Regeneron Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2012-11-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01197391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01197391, "Ascending Dose Study of the Safety and Tolerability of REGN728 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01197391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*